HB1123 — An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses.

HB1123 — An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses. · Informed CitizenryThe Coronavirus Infection Medication Act provides for the prescribing and dispensing of drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infec…Open in Informed Citizenry